Clinical trial Recruiting at 1 site Interventional Ages 12 to 17

How teenagers with and without myopia hold things and move when wearing different eyeglass prescriptions

Official title: Comportement Visuo-postural Des Adolescents Myopes et Non Myopes (CALYPSO)

Run by Essilor International · NCT07440134 · Data updated 2026-11-12

This study will test whether different eyeglass prescriptions, including Stellest lenses, change how close teenagers hold objects and how they move during everyday near tasks.

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment100 (estimated)
SponsorEssilor International
Industry-sponsored
Locations1 site (Paris)
StatusRecruiting
StartedApril 3, 2026
Main results expectedMay 2027
Study endsMay 2027
Registry record updatedSeptember 17, 2026
Trial IDNCT07440134 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are French-speaking adolescents aged 12 to 17 years and 6 months with no visual or cognitive disorders, who are either non-myopic within the specified refraction range or myopic with a prescription between -6.5D and -0.5D and who wear single-vision or Stellest lenses (Stellest wearers must have used them for at least two months).

Probably not a fit

Those unlikely to benefit include people outside the 12–17.5 age range, those with eye disease or cognitive impairments, non–French speakers, and individuals who cannot attend in-person visits at the Paris site.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares three groups of 12- to 17.5-year-old adolescents: non-myopic teens, myopic teens wearing single-vision lenses, and myopic teens wearing Essilor Stellest lenses. Participants first receive an optometric exam and then return for a motion-capture session while doing everyday near tasks, during which eye-to-object distance and postural movements are measured. The investigators will compare average working distances and posture metrics across the three groups to see if lens type is associated with different visual or postural behavior. The study is conducted at a single site in Paris and is sponsored by Essilor International.

Why it matters

Potential benefit: If results show lens type affects working distance or posture, the findings could help clinicians and families choose lenses that reduce close viewing behaviors linked to eye strain or myopia progression.

How similar studies have gone: Myopia-control lenses such as Stellest have demonstrated effectiveness at slowing myopia progression in previous clinical trials, but using motion-capture to compare working distance and posture across lens types is a relatively new application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Volunteer adolescent, fluent in French, able to follow protocol and read and write
* Aged between 12 and 17 years and 6 months
* Adolescent with no history, according to the participant and/or their legal representatives, of any pathology, deficit, or disorder that could interfere with visual or cognitive functions.
* If the subject wears glasses, they must have an ophthalmic prescription dated within the last year, certifying that a consultation was carried out during the previous year
* If the subject wears Essilor® Stellest® 1.0 lenses, they must have worn them for at least two (2) consecutive months prior to inclusion in the study.
* If the subject is nearsighted: -6.5D ≤ equivalent sphere ≤ -0.5D with usual correction
* If the subject is not nearsighted: -0.5 \< equivalent sphere ≤ +2.5

Exclusion Criteria:

* Age \< 12 years
* Age \> 17 years and 6 months
* Pregnant or breastfeeding women (Article L1121-5)
* Persons (legal representatives or subjects) deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent pursuant to Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8 and persons admitted to a health or social care facility for purposes other than research
* Participants who are currently excluded from another study
* All categories of persons who are particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code)
* Declared neurological deficit, in particular a history of epileptic pathology or sensorimotor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders)
* Severe declared eye disease involving loss of visual field, such as glaucoma, involving loss of acuity and severe discomfort in low-light or overly bright environments, such as retinitis pigmentosa, or declared and treated dry eye syndrome.
* Gougerot-Sjögren syndrome or declared dry eye syndrome
* Declared aphakia or pseudophakia (intraocular implant)
* Declared systemic pathology, medical treatment, or medication with an effect on vision
* People with declared muscle paralysis
* Binocular vision problems such as amblyopia, strabismus, or nystagmus
* Children of employees or employees of Essilor International, Luxottica, GrandVision, and their subsidiaries
* Individuals who have undergone previous refractive surgery, have a history of strabismus surgery, or have a history of any type of eye surgery

Where it's running

  • Paris Bastille
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.